|
2025
|
Invention
|
Combination of lurbinectedin and immune checkpoint inhibitors.
Described are combination therapi... |
|
|
G/S
|
Pharmaceuticals, medical and veterinary preparations; Sanitary preparations for medical purposes;... |
|
2024
|
G/S
|
Science and technology services; Oncology research services; Pharmaceutical research and developm... |
|
|
Invention
|
Lurbinectedin, ecubectedin and a related compound for use in the treatment of skin cancers. The p... |
|
|
Invention
|
Lurbinectedin as mcl-1 inhibitor and combinations thereof for use in treating cancer. The present... |
|
|
Invention
|
Plitidepsin for use in the treatment of non-integrated dna viral infections. The present inventio... |
|
2023
|
Invention
|
Lurbinectedin and cyp3a4 inhibitor combination. Described are combination therapy for the treatme... |
|
|
Invention
|
Lurbinectedin and doxorubicin combination. Described are combination therapy for the treatment of... |
|
|
Invention
|
Synthetic process for the manufacture of ecteinascidin compounds. The present invention relates p... |
|
|
Invention
|
Lyophilized pharmaceutical composition and uses of a crystallized form of lurbinectedin.
The pre... |
|
|
Invention
|
Crystallized form of lurbinectedin and method of making the same.
The present invention relates ... |
|
|
Invention
|
Method of treating sclc and managing neutropenia. Provided are methods for the treatment of SCLC ... |
|
|
Invention
|
Stable lurbinectedin composition.
Provided are methods for the treatment of SCLC patients by adm... |
|
|
Invention
|
Method of treating sclc and managing hepatotoxicity. Provided are methods for the treatment of SC... |
|
|
Invention
|
A lyophilized pharmaceutical composition.
The present invention relates to form B of lurbinected... |
|
|
Invention
|
Lurbinectedin composition and methods making the same.
Provided are methods for the treatment of... |
|
|
Invention
|
Method of treating sclc and managing thrombocytopenia. Provided are methods for the treatment of ... |
|
|
G/S
|
Pharmaceutical preparations for treating cancer; Veterinary preparations in the nature of veterin... |
|
|
Invention
|
Antitumoral compounds. A compound of general formula I and pharmaceutical compositions, kits, met... |
|
|
Invention
|
Combination therapy with an antitumor alkaloid.
The present invention relates to the combination... |
|
2022
|
Invention
|
Lurbinectedin and atezolizumab combinations.
Described are combination therapies for the treatme... |
|
|
Invention
|
Lurbinectedin and atezolizumab combinations. Described are combination therapies for the treatmen... |
|
|
G/S
|
Electronic publications, downloadable; Computer software applications, downloadable. Books, Newsp... |
|
|
Invention
|
Antitumoral compounds.
A compound of general formula (I), wherein X takes various meanings, for ... |
|
|
Invention
|
Antitumoral compounds. A compound of general formula (I), wherein X takes various meanings, for u... |
|
|
Invention
|
Dosage regimens for ecubectedin.
The present invention relates to a compound of formula (I), or ... |
|
|
Invention
|
Dosage regimens for ecubectedin. The present invention relates to a compound of formula (I), or a... |
|
|
G/S
|
Pharmaceutical products and preparations for use in the therapeutic area of human oncology |
|
2021
|
G/S
|
Chemicals for use in the manufacture of pharmaceuticals Pharmaceutical products and preparations ... |
|
|
Invention
|
Antibody drug conjugates. D is a drug moiety having the following formula (I) or a pharmaceutical... |
|
|
Invention
|
Lurbinectedin and irinotecan combinations. Described are combination therapies for the treatment ... |
|
|
Invention
|
Combination of lurbinectedin and immune checkpoint inhibitor.
Described are combination therapie... |
|
|
G/S
|
Pharmaceuticals; Veterinary preparations and substances; Sanitary preparations for medical purpos... |
|
|
Invention
|
Drug antibody conjugates.
Drug conjugates having formula [D-(X)b-(AA)w-(T)g-(L)-]n-Ab wherein: D... |
|
|
Invention
|
Drug antibody conjugates. bwgnbwgg if any, or (L); that are useful in the treatment of cancer. |
|
|
Invention
|
Compounds for use in the treatment of coronavirus infection.
A compound of general formula (I) w... |
|
|
Invention
|
Pld for use in combination in the treatment of coronavirus.
The use of PLD with one or more furt... |
|
|
Invention
|
Compounds for use in viral infections.
The present invention relates to the use of compounds in ... |
|
|
Invention
|
Pld for use in combination in the treatment of coronavirus. The use of PLD with one or more furth... |
|
|
Invention
|
Compounds for use in the treatment of coronavirus infection. 11717 take various meanings, for use... |
|
|
Invention
|
Compounds for use in autoimmune conditions. The present invention relates to the use of compounds... |
|
|
Invention
|
Compounds for use in viral infections. The present invention relates to the use of compounds in t... |
|
|
Invention
|
Compounds for use in inflammatory conditions. The present invention relates to the use of compoun... |
|
2020
|
Invention
|
New solid state form of lurbinectedin.
The present invention relates to form B of lurb... |
|
|
Invention
|
New solid state form of lurbinectedin. The present invention relates to form B of lurbinectedin o... |
|
|
Invention
|
Combination of lurbinectedin and immune checkpoint inhibitor. Described are combination therapies... |
|
|
Invention
|
Lurbinectedin in the treatment of malignant mesothelioma.
The use of Lurbinectedin in the treatm... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer for human use and veterinary use in all a... |
|
|
G/S
|
Pharmaceutical products; Veterinary products and
substances; hygiene and sanitary products for m... |
|
|
Invention
|
Methods of treating small cell lung cancer with lurbinectedin formulations.
Provided are methods... |
|
|
Invention
|
Methods of treating small cell lung cancer with lurbinectedin formulations. Provided are methods ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer for human and veterinary use in all animals |
|
|
Invention
|
Compounds for use in autoimmune conditions.
The present invention relates to the use of compound... |
|
2019
|
G/S
|
Pharmaceutical products; preparations for medical and
veterinary use; hygiene and sanitary produ... |
|
|
Invention
|
Anticancer compounds. Anticancer compounds of formula (I) and derivatives thereof are provided.
|
|
|
Invention
|
Antibody drug conjugates comprising ecteinascidin derivatives.
Drug conjugates having formula [D... |
|
|
G/S
|
Pharmaceuticals; Medical and veterinary preparations; Sanitary preparations for medical purposes;... |
|
2018
|
Invention
|
Anticancer compounds.
Anticancer compounds of general formula I
Anticancer compounds of genera... |
|
2017
|
G/S
|
Pharmaceuticals and veterinary preparations for use in oncology. |
|
2016
|
G/S
|
Pharmaceutical and veterinary preparations, namely pharmaceutical preparations for the treatment ... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
|
G/S
|
Bio-active pharmaceutical preparations of natural origin, obtained by synthesis and excluding die... |
|
|
G/S
|
Pharmaceutical preparations; Medical and veterinary preparations; Sanitary preparations for medic... |
|
|
G/S
|
Pharmaceutical products and preparations for use in the therapeutic area of human oncology |
|
2015
|
G/S
|
Chemicals used in industry, science and photography, as well as agriculture, horticulture and for... |
|
2014
|
G/S
|
Pharmaceutical and veterinary products; sanitary products
for medical purposes; dietetic substan... |
|
|
G/S
|
Chemicals for use in the manufacture of pharmaceuticals; pharmaceutical preparations for use in o... |
|
2010
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
